#DiscoverBeautyRest with SLEEP IN BEAUTY and wake up to rejuvenated mornings with Glutathione, Collagen, Melatonin, and Magnesium
The Hidden Risk of GLP-1 Medications: Osteopenia and How to Protect Your Bone Health Anneliese Cadena, A-GNP-C, MSN, RN Feb 5, 2025 3 min read GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) have revolutionized weight management and diabetes care, offering significant benefits in blood sugar control, appetite suppression, and weight loss
Meet clinical BMI criteria and have no contraindications: If your BMI is 30 or higher (or 27+ with weight-related health conditions), and you don't have personal or family history of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2, or other contraindications listed in the safety information, you may be a medically appropriate candidate for GLP-1 treatment
L-carnitine has been proposed as a treatment for a variety of metabolic abnormalities in ESRD, including hypertriglyceridemia, hypercholesterolemia, and anemia
(2021) Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes
Medicaid provides coverage for GLP-1 receptor agonists for the same criteria as Medicare in all states and for weight loss alone in nine states